Literature DB >> 13913645

Experimental evaluation of potential anticancer agents. VI. Anatomical distribution of leukemic cells and failure of chemotherapy.

H E SKIPPER, F M SCHABEL, M W TRADER, J R THOMSON.   

Abstract

Entities:  

Keywords:  ANTINEOPLASTIC AGENTS/pharmacology; LEUKEMIA/experimental

Mesh：

Substances：

Year:  1961        PMID： 13913645

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  7 in total

Review 1.  Drug resistance in oncology: from concepts to applications.

Authors:  J L Cazin; P Gosselin; P Cappelaere; J Robert; A Demaille
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

2.  CGP 6809, a sugar-containing nitrosourea derivative: pharmacological and physicochemical properties.

Authors:  K Schieweck; J Stanek; P M Kanter; K H Schmidt-Ruppin; M Müller; A Matter
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

Review 3.  Targeting O⁶-methylguanine-DNA methyltransferase with specific inhibitors as a strategy in cancer therapy.

Authors:  Bernd Kaina; Geoffrey P Margison; Markus Christmann
Journal:  Cell Mol Life Sci       Date:  2010-08-18       Impact factor: 9.261

4.  The 9L rat brain tumor: description and application of an animal model.

Authors:  M Weizsaecker; D F Deen; M L Rosenblum; T Hoshino; P H Gutin; M Barker
Journal:  J Neurol       Date:  1981       Impact factor: 4.849

5.  Antimicrobial evaluation of 1-methyl-3-nitro-1-Nitrosoguanidine.

Authors:  D E Hunt; R F Pittillo
Journal:  Appl Microbiol       Date:  1968-12

6.  L1210 leukemia i.v. implanted as a model for testing short-chain nitrosourea analogs.

Authors:  J R Schmid; H H Fiebig; G Eisenbrand; G W Löhr
Journal:  J Cancer Res Clin Oncol       Date:  1986       Impact factor: 4.553

7.  Chemical stability of ecomustine, a new antitumor agent in aqueous and biological media as assessed by high-performance liquid chromatography.

Authors:  I el Abed; P Roger; C Gosse; G Atassi; A Gouyette
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.